Australia Stock Exchange release from ORTHOCELL : Striate US Market Entry Update
27/02/2022 22:24
Australia Stock Exchange release from ORTHOCELL OCC.AX : Striate US Market Entry Update
Recent news on Orthocell
See all newsBrief: Orthocell Reports September Quarter Revenue Of A$3.6 Million
Australia's Orthocell rises as flagship product records first Thailand sales
Brief: Orthocell Says QTRLY A$3.2 Million Revenue Achieved
Australia's Orthocell set for best week since November 2024 on US DoD approval for key product
Brief: Orthocell's First Surgical Use Of Remplir In US Department Of Defense